Kubota Pharmaceutical Holdings Co., Ltd.
Research Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) on Bullrun: market cap JPY 10.05B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4596.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 10.05B
- Financial periodFY2025
- RevenueJPY 21.34M
- Revenue growth-21.5%
- Net income-JPY 676.25M
- Free cash flow-JPY 593.63M
- Gross margin-22.5%
Valuation Snapshot
latest market cap is JPY 10.05B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 21.34M | -JPY 676.25M | -JPY 593.63M | -22.5% | -10.59 | JPY 1.92B | JPY 127.87M | JPY 1.81B |
| FY2024 | JPY 27.19M | -JPY 1.33B | -JPY 1.24B | 81.0% | -23.65 | JPY 1.45B | JPY 63.33M | JPY 1.39B |
| FY2023 | JPY 39.89M | -JPY 1.49B | -JPY 1.40B | 70.5% | -26.79 | JPY 2.77B | JPY 252.94M | JPY 2.65B |
| FY2022 | JPY 8.25M | -JPY 2.02B | -JPY 2.14B | 29.5% | -40.92 | JPY 4.05B | JPY 343.02M | JPY 3.95B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 10.05B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About Kubota Pharmaceutical Holdings Co., Ltd.
Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Kubota Pharmaceutical Holdings Co., Ltd.'s market cap?
Kubota Pharmaceutical Holdings Co., Ltd.'s market capitalization is JPY 10.05B.
What does Kubota Pharmaceutical Holdings Co., Ltd. do?
Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials. The company was founded in 2002 and is headquartered in Minato, Japan.